Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) today announced that Johnson & Johnson Innovation-JJDC, Inc. (NYSE: JNJ), an existing stockholder of Achillion ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE